 - Have had other cancer within the past 5 years with the exception of the following cancers: non-melanomatous skin cancer, localized prostate cancer, carcinoma in situ CIS of the cervix, or superficial bladder cancer. Treatment of the exceptions must have ended 6 months before registration into this study 